Treatment Resistant Generalized Myasthenia Gravis clinical trials

Explore recruiting treatment resistant generalized myasthenia gravis clinical trials.

Recruiting treatment resistant generalized myasthenia gravis studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Treatment Resistant Generalized Myasthenia Gravis trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

An open-label, multi-center, phase I/II study to assess safety, efficacy, and cellular kinetics of YTB323 in participants with treatment-resistant generalized myasthenia gravis

France

Phase I and Phase II (Integrated)- Other EU CTIS Study details

Treatment Resistant Generalized Myasthenia Gravis trials by city

Treatment Resistant Generalized Myasthenia Gravis in Toronto Treatment Resistant Generalized Myasthenia Gravis in Vancouver Treatment Resistant Generalized Myasthenia Gravis in Montreal Treatment Resistant Generalized Myasthenia Gravis in Calgary Treatment Resistant Generalized Myasthenia Gravis in Edmonton Treatment Resistant Generalized Myasthenia Gravis in Ottawa Treatment Resistant Generalized Myasthenia Gravis in Winnipeg Treatment Resistant Generalized Myasthenia Gravis in Quebec City Treatment Resistant Generalized Myasthenia Gravis in Hamilton Treatment Resistant Generalized Myasthenia Gravis in Kitchener Treatment Resistant Generalized Myasthenia Gravis in London Treatment Resistant Generalized Myasthenia Gravis in Halifax Treatment Resistant Generalized Myasthenia Gravis in New York Treatment Resistant Generalized Myasthenia Gravis in Los Angeles Treatment Resistant Generalized Myasthenia Gravis in Chicago Treatment Resistant Generalized Myasthenia Gravis in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease